Cynata Therapeutics Ltd has released a press release.
Cynata Receives $1.65m R&D Tax Incentive Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Notice of Allowance for Cynata US Patent
- New Kidney Transplantation Clinical Trial for Cynata & LUMC
- Notice of Allowance for Australia & Canada Cymerus Patents
- Successful Completion of Planned DSMB Review of DFU Trial
- Grant Award to Fund Study of Cynata MSCs in Heart Disease
Later from Cynata Therapeutics
- Notice of Acceptance for Cynata Australian Patent
- Cynata Receives IRB Approval for aGvHD Clinical Trial
- Cynata Adds New Sites for DFU Clinical Trial
- Cynata completes $5.0m Placement and launches SPP
- Capital Raising Presentation
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics